so they will fly thru these clinical procedures with a very clear direction as to what the FDA has advised which would mean that once submitted for regulatory approval, that approval process will be much shorter than expected. That is very good news. Sounds like design freeze is done
Sounds like Titan could also stagger their indications for approval. They could be doing clinical trials for benign hysteroctmy right now and once that is complete submit for that indication.
Market Data 
Markets 
AI
